Steve Demas

Associate Director, Clinical Operations Program Management · Biogen

Steve Demas is an expert in the pharmaceutical industry specializing in clinical trials, pharmaceutics, oncology and clinical monitoring.

Therapeutic Areas Oncology Pharmaceutical Industry Clinical Operations Clincal Development

Geoffrey Joyce, PhD

Associate Professor & Chair of the Department of Pharmaceutical and Health Economics · USC School of Pharmacy

Geoffrey Joyce is an expert in health care economics, including the impact of Medicare Part D, drug benefit design and costs of disease.

Drug benefit design Health Care Economics Medicare Part D Aging and Chronic Disease Hiv / Aids

Judith Cone, M.S.

Vice Chancellor for Innovation, Entrepreneurship and Economic Development, UNC-Chapel Hill · UNC-Chapel Hill

Putting important ideas to use for the public good

Entrepeneurship Innovation & Economic Development Management & Leadership Humanitarian Affairs Commercialization

Kristen Smithwick

Vice President of Business Development, Marketing, and Strategic Planning · Thought Leader Select

Healthcare research and consulting leader available for corporate training/workshops on thought leaders in medicine

Key Opinion Leaders Centers of Excellence Kol Identification Kol Mapping Kol Engagement

Gerry Brunk

Managing Director · Lumira Ventures

Gerry Brunk is a venture capital investor with expertise in biotechnology, medical devices, start-ups and corporate strategy.

Business Strategy Medical Devices Pharmaceutical Industry Drug Development Commercialization

Nancy Pire-Smerkanich, DRSc, MS

Assistant Professor of Regulatory and Quality Sciences · USC School of Pharmacy

Nancy Pire-Smerkanich brings over 30 years of industry experience in drug development to academia

Regulatory Filing Strategy Clinical Regulatory Guidance Drug Development

Stan Gee Louie, PharmD

Professor of Clinical Pharmacy & Director of Clinical Experimental Therapeutics Program · USC School of Pharmacy

Stan Gee Louie is a clinical and translational pharmacologist with three decades of clinical and drug development experience.

Accelerating wound healing properties Developing novel drug therapy to inhibit chronic inflammation in cancer, diabetes, and neurodegenerative disease. Drug development targeting viral infection and cancer. Metabolomic approaches to dissecting the molecular mechanism(s) driving pharmacologic responses.

Stephen Frye, Ph.D.

Fred Eshelman Distinguished Professor of Pharmacy & Director, Center for Integrative Biology and Drug Discovery · UNC-Chapel Hill

Stephen Frye is a professor and director of the Center for Integrative Chemical Biology and Drug Discovery.

Chromatin Chemical Biology Medicinal Chemistry Drug Discovery Oncology

Please enter the email address you signed up with. We will send you an email that you can use to reset your password.

Please check your inbox

We will send you an email to reset your password.